Image via Wikipedia
It raises hopes that kidney disease patients will one day be able to grow their own new organs with no risk of rejection.
Kidneys 5mm long – the size of those in foetuses – were made using a combination of cells from amniotic fluid, which surrounds babies in the womb, and animal foetal cells.
It is hoped the organs could be grown to maturity if implanted in a patient. In future, people’s amniotic fluid could be retained at birth, allowing it to be used later if they develop kidney disease.
‘The idea is to start with human
Image by steve p2008 via Flickr
After making news on several occasions, scientists may have made a definitive breakthrough, with the first possible transfusion using blood obtained from embryonic stem cells possibly coming within the next three years. The transfusion would be done with type O blood, which can be donated to any patient, and would be obtained by researchers using excess embryos from assisted fertilization. The project, which will be led by Marc Turner of Edinburgh University, will also receive contributions from the Transfusion and Transplant Service of the British National Health Service, as well as the
Official opening of Scottish Centre for Regenerative Medicine and bio-incubator facility, Nine, marks milestone in the growth of Edinburgh BioQuarter.
Research into conditions such as multiple sclerosis and heart and liver disease will benefit from multi-million stem cell research and life sciences facilities due to be opened today (Monday, 28th May) by HRH, the Princess Royal.
The Princess Royal unveiled plaques this afternoon at the £54 million Scottish Centre for Regenerative Medicine (SCRM) and £24 million bio-incubator facility, Nine, in Edinburgh.
The University of Edinburgh’s Scottish Centre for Regenerative Medicine will carry out cutting-edge stem cell research to help find therapies for